SUV39H1 mediated SIRT1 trans-repression contributes to cardiac ischemia–reperfusion injury

Guang Yang; Xinjian Zhang; Xinyu Weng; Peng Liang; Xin Dai; Sheng Zeng; Huihui Xu; Hailin Huan; Mingming Fang; Yuehua Li; Dachun Xu; Yong Xu

doi:10.1007/s00395-017-0608-3

SUV39H1 mediated SIRT1 trans-repression contributes to cardiac ischemia–reperfusion injury

Guang Yang
, Xinjian Zhang
, Xinyu Weng
, Peng Liang
, Xin Dai
, Sheng Zeng
, Huihui Xu
, Hailin Huan
, Mingming Fang
, Yuehua Li
, Dachun Xu
, Yong Xu

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Abstract

Ischemic reperfusion (I/R) contributes to deleterious cardiac remodeling and heart failure. The deacetylase SIRT1 has been shown to protect the heart from I/R injury. We examined the mechanism whereby I/R injury represses SIRT1 transcription in the myocardium. There was accumulation of trimethylated histone H3K9 on the proximal SIRT1 promoter in the myocardium in mice following I/R injury and in cultured cardiomyocytes exposed to hypoxia–reoxygenation (H/R). In accordance, the H3K9 trimethyltransferase SUV39H1 bound to the SIRT1 promoter and repressed SIRT1 transcription. SUV39H1 expression was up-regulated in the myocardium in mice following I/R insults and in H/R-treated cardiomyocytes paralleling SIRT1 down-regulation. Silencing SUV39H1 expression or suppression of SUV39H1 activity erased H3K9Me3 from the SIRT1 promoter and normalized SIRT1 levels in cardiomyocytes. Meanwhile, SUV39H1 deficiency or inhibition attenuated I/R-induced infarction and improved heart function in mice likely through influencing ROS levels in a SIRT1-dependent manner. Therefore, our data uncover a novel mechanism for SIRT1 trans-repression during cardiac I/R injury and present SUV39H1 as a druggable target for the development of therapeutic strategies against ischemic heart disease.

Original language	English (US)
Article number	22
Journal	Basic research in cardiology
Volume	112
Issue number	3
DOIs	https://doi.org/10.1007/s00395-017-0608-3
State	Published - May 1 2017
Externally published	Yes

Bibliographical note

Funding Information:
This work was supported, in part, by grants from the Natural Science Foundation of China (91439106, 81670223, 81470418, 81270194, and 81270292), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). HLH was supported by an intramural grant (CX135040) from Jiangsu Agriculture Science and Technology Innovation Fund. YX and YHL are Fellows at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine.

Publisher Copyright:
© 2017, Springer-Verlag Berlin Heidelberg.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Epigenetics
Ischemia–reperfusion injury
SIRT1
SUV39H1
Transcriptional regulation

Publisher link

10.1007/s00395-017-0608-3

Find It

Find It at U of M Libraries

Cite this

@article{1bf651386e854f668be7d6dc6520d85b,

title = "SUV39H1 mediated SIRT1 trans-repression contributes to cardiac ischemia–reperfusion injury",

abstract = "Ischemic reperfusion (I/R) contributes to deleterious cardiac remodeling and heart failure. The deacetylase SIRT1 has been shown to protect the heart from I/R injury. We examined the mechanism whereby I/R injury represses SIRT1 transcription in the myocardium. There was accumulation of trimethylated histone H3K9 on the proximal SIRT1 promoter in the myocardium in mice following I/R injury and in cultured cardiomyocytes exposed to hypoxia–reoxygenation (H/R). In accordance, the H3K9 trimethyltransferase SUV39H1 bound to the SIRT1 promoter and repressed SIRT1 transcription. SUV39H1 expression was up-regulated in the myocardium in mice following I/R insults and in H/R-treated cardiomyocytes paralleling SIRT1 down-regulation. Silencing SUV39H1 expression or suppression of SUV39H1 activity erased H3K9Me3 from the SIRT1 promoter and normalized SIRT1 levels in cardiomyocytes. Meanwhile, SUV39H1 deficiency or inhibition attenuated I/R-induced infarction and improved heart function in mice likely through influencing ROS levels in a SIRT1-dependent manner. Therefore, our data uncover a novel mechanism for SIRT1 trans-repression during cardiac I/R injury and present SUV39H1 as a druggable target for the development of therapeutic strategies against ischemic heart disease.",

keywords = "Epigenetics, Ischemia–reperfusion injury, SIRT1, SUV39H1, Transcriptional regulation",

author = "Guang Yang and Xinjian Zhang and Xinyu Weng and Peng Liang and Xin Dai and Sheng Zeng and Huihui Xu and Hailin Huan and Mingming Fang and Yuehua Li and Dachun Xu and Yong Xu",

note = "Funding Information: This work was supported, in part, by grants from the Natural Science Foundation of China (91439106, 81670223, 81470418, 81270194, and 81270292), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). HLH was supported by an intramural grant (CX135040) from Jiangsu Agriculture Science and Technology Innovation Fund. YX and YHL are Fellows at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. Publisher Copyright: {\textcopyright} 2017, Springer-Verlag Berlin Heidelberg.",

year = "2017",

month = may,

day = "1",

doi = "10.1007/s00395-017-0608-3",

language = "English (US)",

volume = "112",

journal = "Basic research in cardiology",

issn = "0300-8428",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "3",

}

TY - JOUR

T1 - SUV39H1 mediated SIRT1 trans-repression contributes to cardiac ischemia–reperfusion injury

AU - Yang, Guang

AU - Zhang, Xinjian

AU - Weng, Xinyu

AU - Liang, Peng

AU - Dai, Xin

AU - Zeng, Sheng

AU - Xu, Huihui

AU - Huan, Hailin

AU - Fang, Mingming

AU - Li, Yuehua

AU - Xu, Dachun

AU - Xu, Yong

N1 - Funding Information: This work was supported, in part, by grants from the Natural Science Foundation of China (91439106, 81670223, 81470418, 81270194, and 81270292), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). HLH was supported by an intramural grant (CX135040) from Jiangsu Agriculture Science and Technology Innovation Fund. YX and YHL are Fellows at the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. Publisher Copyright: © 2017, Springer-Verlag Berlin Heidelberg.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Ischemic reperfusion (I/R) contributes to deleterious cardiac remodeling and heart failure. The deacetylase SIRT1 has been shown to protect the heart from I/R injury. We examined the mechanism whereby I/R injury represses SIRT1 transcription in the myocardium. There was accumulation of trimethylated histone H3K9 on the proximal SIRT1 promoter in the myocardium in mice following I/R injury and in cultured cardiomyocytes exposed to hypoxia–reoxygenation (H/R). In accordance, the H3K9 trimethyltransferase SUV39H1 bound to the SIRT1 promoter and repressed SIRT1 transcription. SUV39H1 expression was up-regulated in the myocardium in mice following I/R insults and in H/R-treated cardiomyocytes paralleling SIRT1 down-regulation. Silencing SUV39H1 expression or suppression of SUV39H1 activity erased H3K9Me3 from the SIRT1 promoter and normalized SIRT1 levels in cardiomyocytes. Meanwhile, SUV39H1 deficiency or inhibition attenuated I/R-induced infarction and improved heart function in mice likely through influencing ROS levels in a SIRT1-dependent manner. Therefore, our data uncover a novel mechanism for SIRT1 trans-repression during cardiac I/R injury and present SUV39H1 as a druggable target for the development of therapeutic strategies against ischemic heart disease.

AB - Ischemic reperfusion (I/R) contributes to deleterious cardiac remodeling and heart failure. The deacetylase SIRT1 has been shown to protect the heart from I/R injury. We examined the mechanism whereby I/R injury represses SIRT1 transcription in the myocardium. There was accumulation of trimethylated histone H3K9 on the proximal SIRT1 promoter in the myocardium in mice following I/R injury and in cultured cardiomyocytes exposed to hypoxia–reoxygenation (H/R). In accordance, the H3K9 trimethyltransferase SUV39H1 bound to the SIRT1 promoter and repressed SIRT1 transcription. SUV39H1 expression was up-regulated in the myocardium in mice following I/R insults and in H/R-treated cardiomyocytes paralleling SIRT1 down-regulation. Silencing SUV39H1 expression or suppression of SUV39H1 activity erased H3K9Me3 from the SIRT1 promoter and normalized SIRT1 levels in cardiomyocytes. Meanwhile, SUV39H1 deficiency or inhibition attenuated I/R-induced infarction and improved heart function in mice likely through influencing ROS levels in a SIRT1-dependent manner. Therefore, our data uncover a novel mechanism for SIRT1 trans-repression during cardiac I/R injury and present SUV39H1 as a druggable target for the development of therapeutic strategies against ischemic heart disease.

KW - Epigenetics

KW - Ischemia–reperfusion injury

KW - SIRT1

KW - SUV39H1

KW - Transcriptional regulation

UR - https://www.scopus.com/pages/publications/85014899685

UR - https://www.scopus.com/pages/publications/85014899685#tab=citedBy

U2 - 10.1007/s00395-017-0608-3

DO - 10.1007/s00395-017-0608-3

M3 - Article

C2 - 28271186

AN - SCOPUS:85014899685

SN - 0300-8428

VL - 112

JO - Basic research in cardiology

JF - Basic research in cardiology

IS - 3

M1 - 22

ER -

SUV39H1 mediated SIRT1 trans-repression contributes to cardiac ischemia–reperfusion injury

Abstract

Bibliographical note

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this